What are the opening hours?

Monday 08:00 - 17:00 Tuesday 08:00 - 17:00 Wednesday 08:00 - 17:00 Thursday 08:00 - 17:00 Friday 08:00 - 17:00

Benta Pharma Industries

Home
Lebanon
Zuq al Kharab
Benta Pharma Industries

Benta Group is a leading pharmaceutical company specialized in manufacturing and marketing high quality pharmaceutical products and medical devices.

Benta Pharma industries (BPI), is a leading pharmaceutical company specialized in manufacturing and marketing high quality pharmaceutical products and medical devices.

21/03/2026

Happy Mother’s Day 👑

19/03/2026

EID MUBARAK 🌙

عيدكم مبارك 🌙

15/03/2026

When Lebanon needs more, we do more! 🇱🇧

08/03/2026

Happy Women's Day 💙

كل عام وأنتِ بخير بمناسبة عيد المرأة 💙

07/03/2026

At Benta, caring goes beyond medicine. ❤️

Our team proudly rolled up their sleeves to donate blood and support the lifesaving mission of the Lebanese Red Cross. 🩸

In times of distress, solidarity matters more than ever. We’re proud of our employees whose compassion and commitment to community truly reflect the spirit of Benta. 🤝

06/03/2026

For a healthier world…we pray that tomorrow brings peace to Lebanon and the entire Arab world. 💙🕊️

22/02/2026

Benta has officially acquired NerPharMa, a pharmaceutical manufacturing company based in Milan, from NMS Group. 🇮🇹

Strategically located in one of Europe’s key pharma hubs, NerPharMa’s facility is accredited by both the EMA and the US FDA, and brings strong expertise in biologics, and high-potency integrated drug product (DP), as well as drug substance (DS) services in oral solid dosages and injectables.

This acquisition significantly strengthens Benta’s European industrial platform and positions us as a true one-stop-shop CMO partner from process chemistry to distribution, across all galenic forms.

A new chapter of growth, innovation, and global collaboration begins.

18/02/2026

Benta Strengthens Its European Presence with the Acquisition of the Italian CDMO NerPharMa in Milan 🇮🇹

Benta has announced the acquisition of NerPharMa, a pharmaceutical manufacturing company located in Milan, Italy, from NMS Group. The acquisition marks a significant step in strengthening Benta’s European industrial platform and expanding its specialized oncology, biologics and high potency manufacturing capabilities.

Strategically located in one of Europe’s leading pharmaceutical hubs, NerPharMa operates a facility accredited by multiple regulatory authorities, including the EMA and the US FDA, and employs over 100 staff members. The site provides comprehensive manufacturing capabilities across biologics and high-potency integrated drug product (DP), as well as drug substance (DS) services in oral solid dosages and injectables. NerPharMa supports a diverse portfolio of active clients, ranging from local businesses to multinational corporations.

“This acquisition represents a significant step forward in expanding Benta’s European operations. It will enable us to enhance our capabilities in complex therapies, such as biologics and high-potency products, while strengthening our international client network. Benta is now positioning well as one stop shop CMO partner in all galenic forms from process chemistry to distribution,” said Bernard Tannoury, Chairman & CEO of Benta Group.

“This divestment marks a pivotal development in our transition towards becoming an organization dedicated to oncology innovation,” stated Dr. Hugues Dolgos, PharmD, CEO of NMS Group. “By focusing our efforts on small molecule and ADCs research and development, we are better positioned to expedite the advancement of the delivery of breakthrough treatments. I am confident that NerPharMa will continue to progress as part of Benta’s global network.”

17/02/2026

Ramadan Kareem 🌙

May this month bring celebration to your days, peace to your heart, and blessings to your home.

15/02/2026

We were honored to welcome H.E. Minister Bandar bin Ibrahim AlKhorayef, Minister of Industry and Mineral Resources of the Kingdom of Saudi Arabia, to our Benta Lyon site in Saint-Génis-Laval.

The visit highlighted Benta’s expanding industrial footprint in Europe and our strategic initiatives in the Kingdom through BPI Saudi, fully aligned with the objectives of Saudi Vision 2030.

At Benta, we are proud to align with the Kingdom’s vision. Beyond advanced pharmaceutical manufacturing, we are actively investing in biotechnology and full-scale oncology projects, contributing to the development of cutting-edge cancer and rare disease therapies and strengthening local industrial capabilities.

This official visit reflects the strength of our cross-border strategic partnerships and our long-term commitment to supporting sustainable healthcare innovation.

We thank H.E. the Minister and his delegation for their valuable visit and constructive discussions.

14/02/2026

Happy Valentine's Day! 💙

04/02/2026

It’s World Cancer Day 💜

Address

Zouk El Kharab 104
Zuq Al Kharab
P.OBOX:7031

Opening Hours

Monday	08:00 - 17:00
Tuesday	08:00 - 17:00
Wednesday	08:00 - 17:00
Thursday	08:00 - 17:00
Friday	08:00 - 17:00

Telephone

+961 4 545 000

Website

http://www.bpi.com.lb/

Alerts

Be the first to know and let us send you an email when Benta Pharma Industries posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Benta Pharma Industries:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Zuq al Kharab?